NEW MJ NEWS

AbbVie to Host First-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2022 financial results on Friday, April 29, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2022-earnings-conference-call-301525364.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$HEMP Hosts the “Restore the Past, Grow the Future” Informational Session

Hemp, Inc. Hosts the “Restore the Past, Grow the Future” Informational Session…

$IMLFF Closes Non-Brokered Private Placement for up to $1,050,000

InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for up to $1,050,000  NOT…

Lexaria Bioscience Corp. (LXRP) (LXX.CN) Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids

Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat…